Scoping review assesses effectiveness of botulinum toxin in children with torticollis and muscular dystrophies, indicating safety and potential benefits.
Background: Botulinum toxin is commonly used to treat movement disorders, but is rarely applied in muscular dystrophies due to concerns about excessive muscle weakening. A clinical case involving a LAMA2-related muscular dystrophy patient showed promising results following botulinum toxin injection, prompting further investigation. The aim of this review was to examine the safety and effectiveness of botulinum toxin injections in two specific populations: children with torticollis and patients with muscular dystrophies. The goal was to explore the existing evidence and potential research gaps of botulinum toxin use as a treatment option in these groups.
No takes yet. Share an insight, caveat, or question.
Nünlist et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: